Prostate Cancer - Results from #26240

Prostate cancer vaccines: Moving therapeutic vaccination forward in the post-Provenge era - Abstract May 1, 2012

Clinical and pathological parameters predicting extracapsular disease in patients undergoing a radical prostatectomy for clinically localized prostate cancer - Abstract May 1, 2012

Image-guided radiation therapy - Abstract May 1, 2012

Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy - Abstract April 30, 2012

Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer - Abstract April 30, 2012

Therapeutic options for advanced prostate cancer: 2011 Update - Abstract April 30, 2012

Prostate cancer chemoprevention by soy isoflavones: Role of intestinal bacteria as the "second human genome" - Abstract April 30, 2012

Measurement of peri-prostatic fat thickness using transrectal ultrasonography (TRUS): A new risk factor for prostate cancer - Abstract April 30, 2012

Periprostatic lymph node metastasis in prostate cancer and its clinical significance - Abstract April 30, 2012

Decision-making process reported by Medicare patients who had coronary artery stenting or surgery for prostate cancer - Abstract April 27, 2012

Blood cells and their use in active immunotherapy of prostate cancer - Abstract April 27, 2012

Understanding fragmentation of prostate cancer survivorship care: Implications for cost and quality - Abstract April 27, 2012

Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: Biochemical outcomes using third generation-based technology - Abstract April 27, 2012

Role of denosumab in prostate cancer - Abstract April 27, 2012

Abiraterone acetate: A guide to its use in metastatic castration-resistant prostate cancer - Abstract April 27, 2012

Targeting prostate cancer stem cells for cancer therapy - Abstract April 27, 2012

An overview of sipuleucel-T: Autologous cellular immunotherapy for prostate cancer - Abstract April 27, 2012

Smokers: At risk for prostate cancer but unlikely to screen - Abstract April 27, 2012

Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer - Abstract April 26, 2012

Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: The Australian perspective - Abstract April 26, 2012

Page 1313 of 1449